Cardiovascular safety in type 2 diabetes with sulfonylureas as second-line drugs: a nation-wide population-based comparative safety study
Wang H, Cordiner RLM, Huang Y, et al.
Diabetes Care. 2023;dc221238.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Wang H, Cordiner RLM, Huang Y, et al.
Diabetes Care. 2023;dc221238.
Leggi
Bue-Valleskey JM, Kazda CM, Ma C, et al.
Diabetes Care. 2023;dc222396.
Leggi
Eldor R, Francis BH, Fleming A, et al
Diabetes Obes Metab. 2023;25(4):943-95.
Leggi
Bélteky M, Milletich PL, Ahrens AP, et al.
Diabetologia. Pub. online 24 Mar 2023.
Leggi
Avari P, Tang W, Jugnee N, et al.
Diabetes Technol Ther. Pub. online 24 Mar 2023.
Leggi
Lee H, Choi J, Kim NY, et al.
Diabetes Care. 2023;dc222144
Leggi
Gedebjerg A, Bjerre M, Kjaergaard AD, et al.
Diabetes Care. 2023;dc221353.
Leggi
Bianchi C, Resi V, Manicardi E, Burlina S, Sculli MA, Formoso G, Sciacca L
NMCD. Pub. online 16 Mar 2023.
Leggi
Hoffmann C, Schwarz PE, Mantzoros CS, et al.
Diabetes Res Clin Pract . Pub. online 18 Mar 2023.
Leggi
Cioana M, Deng J, Nadarajah A, et al.
JAMA Netw Open. 2023;6(3):e231887.
Leggi